Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METS: Metformin for Antipsychotic-Induced Weight Gain
NCT00816907Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jan 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in antipsychotic-induced weight gain (AIWG), sponsored by National Institute of Mental Health. Started Jan 2009; status: completed.
02
Drugs
metformin
03
Conditions
antipsychotic-induced weight gain (AIWG)
Beyond the preview
Go deeper on NCT00816907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816907.